Cancer Registry Software Market

Cancer Registry Software Market by Type (Standalone, Integration), Delivery (On-premise, Cloud), Database (Commercial, Public), Functionality (Cancer Reporting, Patient Care, Medical Research), End User, Region - Forecast to 2024

Report Code: HIT 6993 Mar, 2019, by marketsandmarkets.com

[124 Pages Report] The cancer Patient Registry Software market is projected to reach USD 91 million by 2024 from USD 56 million in 2019, at a CAGR of 10.4% during the forecast period. Factors such as the increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance are driving the growth of this market. However, factors such as privacy and data security-related concerns are expected to restrain the growth of this market to a certain extent.

Cancer Registry Software Market

Standalone software segment dominated the cancer patient registry software market, by type, in 2018

Based on type, the cancer patient registry software market is segmented into standalone and integrated software. The standalone software segment accounted for a larger share in 2018 primarily due to the significant use of standalone software by government organizations & TPAs for Population Health Management (due to its adaptability and interoperability). Also, standalone software provides practical and easy-to-use tools to store and process registry data, while standalone software customized for patient registries offers higher flexibility and features such as multiple system usage and automatic upgradation.

Research centers segment to witness the highest growth in the cancer patient registry software market, by end user

Based on end user, the global cancer registry software industry is segmented into private payers; hospitals & medical practices; research centers; pharmaceutical, biotechnology, & medical device companies; and government organizations & third-party administrators. The research centers segment is estimated to grow at the highest CAGR during the forecast period. Research centers use cancer patient registry software primarily to track patients who are eligible for clinical trials and product development.

Cancer Registry Software Market

North America will continue to dominate the cancer patient registry software market during the forecast period

In 2018, North America accounted for the largest share of the cancer patient registry software market. This regional market is also estimated to grow at a higher CAGR during the forecast period. This can be attributed to the high burden of cancer, government funding initiatives to encourage the development of cancer registries, high investments in healthcare IT, presence of major cancer registry software-developing players, and the high adoption rate of these solutions in the region.

Key players in the cancer patient registry software market

The cancer patient registry software market is highly consolidated in nature with a limited number of players operating in it. Prominent players in this market include Elekta (Sweden), Electronic Registry Systems, Inc. (US), Onco, Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US), and McKesson Corporation (US).

Elekta is one of the leading providers of clinical software and equipment for cancer care and brain disorders. Elekta’s key expertise lies in precision radiation medicine. The company provides cost-effective and high-quality cancer care services and software to its customers. It offers cancer patient registry software through its Oncology Informatics segment. Elekta’s cancer registry software is designed with a highly detailed database that helps end users to gain insights into overall patient outcomes.

Electronic Registry Systems (ERS) is another leading player in the cancer patient registry software market. The cancer registry software solution provided by the company helps in recording and reporting important cancer patient information. Moreover, the company’s cloud-based CRStar technology helps in curtailing ongoing costs and minimizes start-up time for hospitals and healthcare facilities. The company caters to various healthcare institutes throughout the US and internationally.

Scope of the report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Type, deployment model, database, functionality, end user, and region

Geographies covered

North America and Europe

Companies covered

Elekta (Sweden), Electronic Registry Systems, Inc. (US), Onco, Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US), and McKesson Corporation (US)

This report categorizes the cancer patient registry software market into the following segments and subsegments:

On the basis of type, the cancer patient registry software market has been segmented as follows:

  • Standalone Software
  • Integrated Software

On the basis of deployment model, the cancer patient registry software market has been segmented as follows:

  • On-premise
  • Cloud-based

On the basis of database, the cancer patient registry software market has been segmented as follows:

  • Commercial Databases
  • Public Databases

On the basis of functionality, the cancer patient registry software market has been segmented as follows:

  • Cancer Reporting to Meet State & Federal Regulations
  • Patient Care Management
  • Product Outcome Evaluation
  • Medical Research and Clinical Studies

On the basis of end user, the cancer patient registry software market has been segmented as follows:

  • Government Organizations & Third-party Administrators (TPAS)
  • Hospitals & Medical Practices
  • Pharmaceutical, Biotechnology, & Medical Device Companies
  • Private Payers
  • Research Centers

On the basis of region, the cancer patient registry software market has been segmented as follows:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE

Recent Developments

  • In April 2017, McKesson Corporation acquired CoverMyMeds (US) to enhance its technology offerings for clinicians, payers, and pharmaceutical manufacturers.
  • In April 2016, McKesson Corporation announced the acquisition of Vantage Oncology, LLC to expand its oncology portfolio.

Key questions addressed by the report

  • Where will all these developments take the industry in the mid-to-long term?
  • What are the factors driving the growth of this market?
  • Who are the key players in the market and how intense is the competition?
  • What are the recent collaborations key players have entered into?
  • What are the recent trends affecting cancer patient registry software manufacturers?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst


Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Sources
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Sources
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 27)

4 Premium Insight (Page No. - 31)
    4.1 Cancer Patient Registry Software: Market Overview
    4.2 Market, By Type
    4.3 Market, By Deployment Model
    4.4 Market, By Database Type
    4.5 Market, By Functionality
    4.6 Market, By End User

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Growing Prevalence of Cancer and Favorable Government Initiatives
                    5.2.1.2 Rising Pressure to Improve the Quality of Care and Reduce Healthcare Costs
                    5.2.1.3 Rising Adoption of Ehrs
                    5.2.1.4 Growing Use of Cancer Patient Registry Data for Post-Marketing Surveillance
           5.2.2 Market Restraints
                    5.2.2.1 Privacy and Data Security-Related Concerns
           5.2.3 Market Opportunities
                    5.2.3.1 Rising Number of Accountable Care Organizations
                    5.2.3.2 Growth of Cloud-Based Cancer Patient Registry Solutions
           5.2.4 Market Challenges
                    5.2.4.1 Lack of Interoperability and Integration
                    5.2.4.2 Reluctance to Adopt Advanced Solutions
                    5.2.4.3 Lack of Awareness

6 Cancer Patient Registry Software Market, By Type (Page No. - 40)
    6.1 Introduction
    6.2 Standalone Software
           6.2.1 Standalone Software Accounts for the Largest Share of the Market
    6.3 Integrated Software
           6.3.1 Advantages Such as Flexibility and Safety are Driving the Adoption of Integrated Software

7 Cancer Patient Registry Software Market, By Deployment Model (Page No. - 46)
    7.1 Introduction
    7.2 On-Premise Models
           7.2.1 On-Premise Models Segment Accounted for the Largest Share of the Market in 2018
    7.3 Cloud-Based Models
           7.3.1 Cost-Effectiveness and Flexibility Have Ensured the Growth of Cloud-Based Models

8 Cancer Patient Registry Software Market, By Database Type (Page No. - 52)
    8.1 Introduction
    8.2 Commercial Databases
           8.2.1 Commercial Databases Segment Hold the Largest Share in the Cancer Patient Registry Software Market
    8.3 Public Databases
           8.3.1 Public Databases are Used for Data Collection for A Specific Research Agenda

9 Cancer Patient Registry Software Market, By Functionality (Page No. - 58)
    9.1 Introduction
    9.2 Cancer Reporting to Meet State and Federal Regulations
           9.2.1 Stringent and Rapidly Changing State and Federal Regulations for Cancer Reporting to Drive the Growth of This Segment
    9.3 Patient Care Management
           9.3.1 Market Players are Expected to Focus on Developing Solutions Designed With Automated Patient Outreach Facility for Optimum Patient Care Management
    9.4 Medical Research & Clinical Studies
           9.4.1 Several Research Organizations are Expected to Support and Encourage the Creation of Registries for Clinical Research
    9.5 Product Outcome Evaluation
           9.5.1 Product Outcome Evaluation Functionality has Major Applications in Post-Marketing Surveillance in the Pharmaceutical Industry

10 Cancer Patient Registry Software Market, By End User (Page No. - 68)
     10.1 Introduction
     10.2 Government Organizations & Third-Party Administrators
             10.2.1 Growing Government Initiatives to Drive the Demand for Cancer Patient Registry Software in This End-User Segment
     10.3 Hospitals & Medical Practices
             10.3.1 Improved Patient Care Management Offered By Cancer Patient Registry Software to Drive Its Demand in Hospitals and Medical Practices
     10.4 Private Payers
             10.4.1 Role of Cancer Patient Registry Software in the Effective Determination of Healthcare Coverage Policies to Drive Its Demand Among Payers
     10.5 Pharmaceutical, Biotechnology, and Medical Device Companies
             10.5.1 Increased Need for Post-Marketing Surveillance Driving the Demand for Cancer Patient Registry Software in This End-User Segment
     10.6 Research Centers
             10.6.1 Cancer Patient Registry Software Makes It Easier for Research Centers to Gather Relevant Information on Cancer Patients

11 Cancer Patient Registry Software Market, By Region (Page No. - 80)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                        11.2.1.1 Rising Adoption of Ehrs and Increased Government Funding to Build Cancer Registries—Key Drivers for Market Growth
             11.2.2 Canada
                        11.2.2.1 Government Initiatives to Encourage Cancer Research and Support Data Collection for Cancer Registries to Contribute to Market Growth
     11.3 Europe
             11.3.1 UK
                        11.3.1.1 Initiatives to Promote and Develop Cancer Registration in the UK to Drive the Growth of This Market
             11.3.2 Germany
                        11.3.2.1 Growing Incidence of Cancer and Ongoing Research Activities to Drive Demand for Registry Software
             11.3.3 France
                        11.3.3.1 Growing Emphasis on Healthcare Interoperability to Drive the Market for Integrated Cancer Patient Registry Software in France
             11.3.4 Rest of Europe (RoE)

12 Competitive Landscape (Page No. - 106)
     12.1 Overview
     12.2 Market Player Ranking
     12.3 Competitive Situation and Trends
             12.3.1 Product Enhancements
             12.3.2 Acquisitions
             12.3.3 Collaborations

13 Company Profiles (Page No. - 110)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     13.1 Onco, Inc.
     13.2 C/Net Solutions
     13.3 Elekta AB (PUB)
     13.4 Rocky Mountain Cancer Data Systems
     13.5 Electronic Registry Systems, Inc.
     13.6 Mckesson Corporation

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 118)
     14.1 Discussion Guide
     14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.3 Related Reports
     14.4 Author Details


List of Tables (96 Tables)

Table 1 Market, By Type, 2017–2024 (USD Million)
Table 2 Standalone Cancer Patient Registry Software: Market, By Region, 2017–2024 (USD Million)
Table 3 North America: Standalone Cancer Patient Registry Software: Market, By Country, 2017–2024 (USD Million)
Table 4 Europe: Standalone Cancer Patient Registry Software: Market, By Country, 2017–2024 (USD Million)
Table 5 Integrated Cancer Patient Registry Software: Market, By Region, 2017–2024 (USD Million)
Table 6 North America: Integrated Cancer Patient Registry Software: Market, By Country, 2017–2024 (USD Million)
Table 7 Europe: Integrated Cancer Patient Registry Software: Market, By Country, 2017–2024 (USD Million)
Table 8 Market, By Deployment Model, 2017–2024 (USD Million)
Table 9 Market for On-Premise Models, By Region, 2017–2024 (USD Million)
Table 10 North America: Market for On-Premise Models, By Country, 2017–2024 (USD Million)
Table 11 Europe: Market for On-Premise Models, By Country/Region, 2017–2024 (USD Million)
Table 12 Market for Cloud-Based Models, By Region, 2017-2024 (USD Million)
Table 13 North America: Market for Cloud-Based Models, By Country, 2017-2024 (USD Million)
Table 14 Europe: Market for Cloud-Based Models, By Country/ Region, 2017-2024 (USD Million)
Table 15 Market, By Database Type, 2017–2024 (USD Million)
Table 16 Market for Commercial Databases, By Region, 2017–2024 (USD Million)
Table 17 North America: Market for Commercial Databases, By Country, 2017–2024 (USD Million)
Table 18 Europe: Market for Commercial Databases, By Country, 2017–2024 (USD Million)
Table 19 Market for Public Databases, By Region, 2017–2024 (USD Million)
Table 20 North America: Market for Public Databases, By Country, 2019–2024 (USD Million)
Table 21 Europe: Market for Public Databases, By Country, 2019–2024 (USD Million)
Table 22 Market, By Functionality, 2017–2024 (USD Million)
Table 23 Market for Cancer Reporting to Meet State and Federal Regulations, By Region, 2017–2024 (USD Million)
Table 24 North America: Market for Cancer Reporting to Meet State and Federal Regulations, By Country, 2017–2024 (USD Million)
Table 25 Europe: Market for Cancer Reporting to Meet State and Federal Regulations, By Country, 2017–2024 (USD Million)
Table 26 Market for Patient Care Management, By Region, 2017–2024 (USD Million)
Table 27 North America: Market for Patient Care Management, By Country, 2017–2024 (USD Million)
Table 28 Europe: Market for Patient Care Management, By Country, 2017–2024 (USD Thousand)
Table 29 Market for Medical Research & Clinical Studies, By Region, 2017–2024 (USD Million)
Table 30 North America: Market for Medical Research & Clinical Studies, By Country, 2017–2024 (USD Million)
Table 31 Europe: Market for Medical Research & Clinical Studies, By Country, 2017–2024 (USD Million)
Table 32 Market for Product Outcome Evaluation, By Region, 2017–2024 (USD Million)
Table 33 North America: Market for Product Outcome Evaluation, By Country, 2017–2024 (USD Million)
Table 34 Europe: Market for Product Outcome Evaluation, By Country, 2017–2024 (USD Million)
Table 35 Market, By End User, 2017–2024 (USD Million)
Table 36 Market for Government Organizations & Third-Party Administrators, By Region, 2017–2024 (USD Million)
Table 37 North America: Market for Government Organizations & Third-Party Administrators, By Country, 2017–2024 (USD Million)
Table 38 Europe: Market for Government Organizations & Third-Party Administrators, By Country, 2017–2024 (USD Million)
Table 39 Market for Hospitals & Medical Practices, By Region, 2017–2024 (USD Million)
Table 40 North America: Market for Hospitals & Medical Practices, By Country, 2017–2024 (USD Million)
Table 41 Europe: Market for Hospitals & Medical Practices, By Country, 2017–2024 (USD Million)
Table 42 Market for Private Payers, By Region, 2017–2024 (USD Million)
Table 43 North America: Market for Private Payers, By Country, 2017–2024 (USD Million)
Table 44 Europe: Market for Private Payers, By Country, 2017–2024 (USD Thousand)
Table 45 Cancer Registry Software Market for Pharmaceutical, Biotechnology, and Medical Device Companies, By Region, 2017–2024 (USD Million)
Table 46 North America: Cancer Registry Software Market for Pharmaceutical, Biotechnology, and Medical Device Companies, By Country, 2017–2024 (USD Million)
Table 47 Europe: Cancer Registry Software Market for Pharmaceutical, Biotechnology, and Medical Device Companies, By Country, 2017–2024 (USD Million)
Table 48 Cancer Registry Software Market for Research Centers, By Region, 2017–2024 (USD Million)
Table 49 North America: Cancer Registry Software Market for Research Centers, By Country, 2017–2024 (USD Million)
Table 50 Europe: Cancer Registry Software Market for Research Centers, By Country, 2017–2024 (USD Million)
Table 51 Cancer Registry Software Market, By Region, 2017–2024 (USD Million)
Table 52 North America: Cancer Registry Software Market, By Country, 2017–2024 (USD Million)
Table 53 North America: Cancer Registry Software Market, By Type, 2017–2024 (USD Million)
Table 54 North America: Cancer Registry Software Market, By Deployment Model, 2017–2024 (USD Million)
Table 55 North America: Cancer Registry Software Market, By Database Type, 2017–2024 (USD Million)
Table 56 North America: Cancer Registry Software Market, By Functionality, 2017–2024 (USD Million)
Table 57 North America: Cancer Registry Software Market, By End User, 2017–2024 (USD Million)
Table 58 US: Cancer Registry Software Market, By Type, 2017–2024 (USD Million)
Table 59 US: Cancer Registry Software Market, By Deployment Model, 2017–2024 (USD Million)
Table 60 US: Cancer Registry Software Market, By Database Type, 2017–2024 (USD Million)
Table 61 US: Cancer Registry Software Market, By Functionality, 2017–2024 (USD Million)
Table 62 US: Cancer Registry Software Market, By End User, 2017–2024 (USD Million)
Table 63 Canada: Cancer Registry Software Market, By Type, 2017–2024 (USD Million)
Table 64 Canada: Cancer Registry Software Market, By Deployment Model, 2017–2024 (USD Million)
Table 65 Canada: Cancer Registry Software Market, By Database Type, 2017–2024 (USD Million)
Table 66 Canada: Cancer Registry Software Market, By Functionality, 2017–2024 (USD Million)
Table 67 Canada: Cancer Registry Software Market, By End User, 2017–2024 (USD Million)
Table 68 Europe: Cancer Registry Software Market, By Country, 2017–2024 (USD Million)
Table 69 Europe: Cancer Registry Software Market, By Type, 2017–2024 (USD Million)
Table 70 Europe: Cancer Registry Software Market, By Deployment Model, 2017–2024 (USD Million)
Table 71 Europe: Cancer Registry Software Market, By Database Type, 2017–2024 (USD Million)
Table 72 Europe: Cancer Registry Software Market, By Functionality, 2017–2024 (USD Million)
Table 73 Europe: Cancer Registry Software Market, By End User, 2017–2024 (USD Million)
Table 74 UK: Cancer Registry Software Market, By Type, 2017–2024 (USD Million)
Table 75 UK: Cancer Registry Software Market, By Deployment Model, 2017–2024 (USD Million)
Table 76 UK: Cancer Registry Software Market, By Database Type, 2017–2024 (USD Million)
Table 77 UK: Cancer Registry Software Market, By Functionality, 2017–2024 (USD Million)
Table 78 UK: Cancer Registry Software Market, By End User, 2017–2024 (USD Million)
Table 79 Germany: Patient Registry Software Market, By Type, 2017–2024 (USD Million)
Table 80 Germany: Patient Registry Software Market, By Deployment Model, 2017–2024 (USD Million)
Table 81 Germany: Cancer Registry Software Market, By Database Type, 2017–2024 (USD Million)
Table 82 Germany: Cancer Registry Software Market, By Functionality, 2017–2024 (USD Million)
Table 83 Germany: Cancer Registry Software Market, By End User, 2017–2024 (USD Million)
Table 84 France: Cancer Registry Software Market, By Type, 2017–2024 (USD Million)
Table 85 France: Cancer Registry Software Market, By Deployment Model, 2017–2024 (USD Million)
Table 86 France: Cancer Registry Software Market, By Database Type, 2017–2024 (USD Million)
Table 87 France: Cancer Registry Software Market, By Functionality, 2017–2024 (USD Million)
Table 88 France: Cancer Registry Software Market, By End User, 2017–2024 (USD Million)
Table 89 RoE: Market, By Type, 2017–2024 (USD Million)
Table 90 RoE: Market, By Deployment Model, 2017–2024 (USD Million)
Table 91 RoE: Market, By Database Type, 2017–2024 (USD Million)
Table 92 RoE: Market, By Functionality, 2017–2024 (USD Million)
Table 93 RoE: Market, By End User, 2017–2024 (USD Million)
Table 94 Product Enhancements, 2016–2018
Table 95 Acquisitions, 2016–2018
Table 96 Collaborations, 2016–2018


List of Figures (29 Figures)

Figure 1 Cancer Patient Registry Software: Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Cancer Patient Registry Software: Market, By Type, 2019 vs 2024 (USD Million)
Figure 8 Cancer Patient Registry Software: Market, By Deployment Model, 2019 vs 2024 (USD Million)
Figure 9 Cancer Patient Registry Software: Market, By Database Type, 2019 vs 2024 (USD Million)
Figure 10 Cancer Patient Registry Software: Market, By Functionality, 2019 vs 2024 (USD Million)
Figure 11 Research Centers Segment is Expected to Witness the Highest CAGR During the Forecast Period
Figure 12 Rising Pressure to Improve the Quality of Care and Reduce Healthcare Costs to Drive Market Growth
Figure 13 Integrated Software Segment to Grow at the Fastest Rate During the Forecast Period
Figure 14 On-Premise Models to Hold the Largest Share of the Market in 2019
Figure 15 Commercial Database Segment to Dominate the Market in 2019
Figure 16 Cancer Reporting to Meet State & Federal Regulations Segment to Dominate the Market in 2019
Figure 17 Hospitals and Medical Practices Segment to Dominate the Market in 2019
Figure 18 Cancer Patient Registry Software: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Integrated Software Segment is Expected to Register High Growth During the Forecast Period
Figure 20 Cloud-Based Models Segment is Expected to Witness the Higher CAGR During the Forecast Period
Figure 21 Commercial Databases Segment to Dominate the Cancer Patient Registry Software: Market During the Forecast Period
Figure 22 Medical Research & Clinical Studies Segment is Expected to Witness the Highest Growth Rate During the Forecast Period
Figure 23 Research Centers - the Fastest-Growing End-User Segment in the Cancer Patient Registry Software: Market
Figure 24 North America: Cancer Patient Registry Software: Market Snapshot
Figure 25 Europe: Cancer Patient Registry Software: Market Snapshot
Figure 26 Key Developments in the Cancer Patient Registry Software: Market From 2016 to November 2018
Figure 27 Cancer Patient Registry Software: Market Player Ranking, 2018
Figure 28 Elekta AB (PUB): Company Snapshot
Figure 29 Mckesson Corporation: Company Snapshot

This study involved four major activities to estimate the current size of the cancer patient registry software market. Information on the market and its peer & parent markets was collected through exhaustive secondary research. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the size of segments and subsegments.

Secondary Research

Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cancer patient registry software market. Secondary sources such as directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers; and annual reports were used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Cancer Registry Software Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cancer patient registry software market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • Revenue generated by leading players through cancer patient registry software has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the cancer patient registry software market on the basis of type, deployment model, database type, functionality, end user, and region
  • To provide detailed information regarding the factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments in North America and Europe
  • To profile key market players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product enhancements, acquisitions, and collaborations in the cancer patient registry software market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for this report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
HIT 6993
Published ON
Mar, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cancer Registry Software Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home